Celros Biotech
Seoul, KR· latest recorded location
Celros Biotech is named on 3 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 5
- Inventors
- 6
- Granted in 2026 so far
- 1
- Most recent grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 8 documents
Recent patents
- Thiohydantoin derivatives and uses thereof25 Aug 2026US 12,714,694 B2
- SH3YL1 antibodies, compositions comprising the same, and vectors and uses thereof23 Dec 2025US 12,503,502 B2
- SH3YL1 antibodies, compositions comprising the same, and vectors and uses thereof19 Dec 2023US 11,845,790 B2
- SH3YL1 Antibodies, Compositions Comprising the Same, and Vectors and Uses Thereof23 Apr 2026US 2026/0109755 A1
- Novel oxadiazole derivative and use thereof13 Feb 2025US 2025/0051293 A1
- SH3YL1 Antibodies, Compositions Comprising the Same, and Vectors and Uses Thereof16 May 2024US 2024/0158485 A1
- Novel thiohydantoin derivatives and uses thereof19 Oct 2023US 2023/0330067 A1
- SH3YL1 Antibodies, Compositions Comprising the Same, and Vectors and Uses Thereof31 Mar 2022US 2022/0098292 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.